Venue: Riverside Stadium, Middlesbrough
The Bionow Pharma Manufacturing conference was a buzzy and packed event, hosting 180 delegates, exhibitors, and speakers. Industry leaders, academics, and regulatory experts exchanged insights, shared expertise, and engaged in meaningful collaboration. Through a dynamic programme of talks, panel discussions, exhibition, and networking opportunities, attendees explored key challenges and emerging opportunities shaping the future of the industry.
Read the full event summary here
Pharma Manufacturing 2025 is kindly supported by Bouygues Energies & Services, Enterprise Ireland, Tees Valley Combined Authority, AstraZeneca, Bristol Myers Squibb, CSL Seqirus, Elanco, FUJIFILM Diosynth Biotechnologies, GSK, Pharmaron, Quotient Sciences and Sterling Pharma Solutions.
Agenda highlights:
Keynote Speakers
- Clare Rawlinson-Malone, Senior Director, Bristol Myers Squibb
- Charlotte Blant, Founder and CEO, TIRO
- Kit Erlebach, Senior Director, Engineering and EHS, FUJIFILM Diosynth Biotechnologies
Set the Scene Panel
Chair: Sophie Walton, Director Of Strategic Partnerships, CPI & Member of Tees Valley CA Business Board
Speakers
- Adeel Aslam, Deputy Managing Director, Bouygues Energies & Services
- Safwan Akram, Professor Biomanufacturing, Engineering Biology & Innovation in Biosciences, Teesside University & RESILIENCE
- Hugo Tuckett, Senior Associate, GK Strategy
- Bethany Dickson, Scientist, AstraZeneca
- Clare Rawlinson-Malone, Senior Director, Bristol Myers Squibb
An Apprentice Journey
Keira Chippendale, Laboratory Science (Microbiology) Degree Apprentice, GSK
Sustainability and Ethics – Case Studies
Chair: Simon Harwood, Head of Quality Control, CSL Seqirus
Speakers
- Adam Harvey, Professor of Process Intensification, Newcastle University & Co-Director, PINZ CDT
- Barry McDermott, Group Head of Sustainability, PM Group
- Rebecca Hobson, Director of QC, Pharmaron
- Sarah-Jayne Smith, Social Values Lead, CSL Seqirus
Growing Modalities
Chair: David Molyneux, VP New Business, Sterling Pharma Solutions
Speakers
- Alan Dickson, COEBP Director, University of Manchester, Centre of Excellence in Biopharmaceuticals (Speaking on Biopharmaceuticals)
- Laura Maray, Research Technologist, Health and Nuclear Medicine, United Kingdom National Nuclear Laboratory Ltd. (Speaking on Nuclear Medicine)
- Iain Pritchard, Site Manager, Bachem (Speaking on Peptides)
- Sara Jenkins, ADC Commercial Manager, Sterling Pharma Solutions (speaking on ADCs)
Emerging Technologies and Therapies
Chair: Stephen Byard, Principal Research Fellow, Quotient Sciences
Speakers
- Francois Taute, Senior Research Biotechnologist, CellRev
- Jessica Sayers, MSAT Lead, CPI
- Emily Butterworth, Laboratory Scientist Apprentice – Microbiology S&T, AstraZeneca
- Laura Thurgood, Research and Business Engagement Manager, Royce Institute
